Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.600 | None | 0.983 | 1494 | 32 | 1988 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.800 | None | 0.944 | 607 | 32 | 1989 | 2020 | ||||||||
|
myotubularin related protein 3 | 0.682 | 0.462 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 19 | 2011 | 2011 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.400 | None | 0.971 | 68 | 18 | 2001 | 2019 | ||||||||
|
HORMA domain containing 2 | 0.716 | 0.385 | 7.1E-05 |
|
disease | 0.120 | None | 1.000 | 2 | 18 | 2011 | 2014 | ||||||||
|
cholinergic receptor nicotinic beta 4 subunit | 0.644 | 0.423 | 0.14 |
|
disease | 0.500 | None | 1.000 | 27 | 16 | 2008 | 2018 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.500 | None | 1.000 | 54 | 15 | 2008 | 2020 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.100 | None | 0.932 | 88 | 12 | 2001 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
disease | 0.500 | None | 0.934 | 61 | 11 | 2008 | 2018 | ||||||||
|
ERCC excision repair 1, endonuclease non-catalytic subunit | 0.445 | 0.846 | 1.6E-07 |
|
disease | 0.600 | None | 0.947 | 38 | 11 | 2005 | 2019 | ||||||||
|
X-ray repair cross complementing 4 | 0.528 | 0.769 | 8.3E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 10 | 2009 | 2011 | ||||||||
|
ERCC excision repair 2, TFIIH core complex helicase subunit | 0.420 | 0.846 | 7.1E-20 |
|
disease | 0.100 | None | 0.948 | 58 | 9 | 2001 | 2019 | ||||||||
|
cellular communication network factor 4 | 0.554 | 0.692 | 6.4E-07 |
|
disease | 0.050 | None | 1.000 | 5 | 9 | 2003 | 2017 | ||||||||
|
CLPTM1 like | 0.551 | 0.654 | 4.4E-05 |
|
disease | 0.500 | None | 0.978 | 45 | 8 | 2008 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.400 | None | 0.875 | 32 | 8 | 2004 | 2019 | ||||||||
|
mucin 4, cell surface associated | 0.506 | 0.769 | 2.8E-54 |
|
disease | 0.060 | None | 1.000 | 6 | 8 | 1996 | 2014 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 0.959 | 49 | 7 | 1989 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.100 | None | 0.971 | 34 | 7 | 2006 | 2019 | ||||||||
|
exonuclease 1 | 0.578 | 0.692 | 8.1E-13 |
|
disease | 0.030 | None | 1.000 | 3 | 7 | 2008 | 2014 | ||||||||
|
HORMAD2 and MTMR3 antisense RNA 1 | 0.839 | 0.308 |
|
disease | 0.100 | None | 1.000 | 1 | 7 | 2011 | 2011 | |||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.400 | None | 0.961 | 129 | 6 | 1989 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.600 | None | 1.000 | 48 | 6 | 2002 | 2020 | ||||||||
|
apurinic/apyrimidinic endodeoxyribonuclease 1 | 0.458 | 0.846 | 1.9E-07 |
|
disease | 0.100 | None | 0.879 | 33 | 6 | 2003 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
disease | 0.400 | None | 0.964 | 28 | 6 | 1977 | 2018 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.100 | None | 1.000 | 21 | 6 | 2001 | 2019 |